Literature DB >> 7697907

ANCA--pathophysiology revisited.

C G Kallenberg1, E Brouwer, A H Mulder, C A Stegeman, J J Weening, J W Tervaert.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7697907      PMCID： PMC1534275          DOI： 10.1111/j.1365-2249.1995.tb03594.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  20 in total

1.  Fatal immune complex glomerulonephritis without deposits.

Authors:  F G Germuth; A J Valdes; J J Taylor; O Wise; E Rodriguez
Journal:  Johns Hopkins Med J       Date:  1975-05

2.  Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells.

Authors:  B H Ewert; J C Jennette; R J Falk
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

3.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.

Authors:  K M Dolman; R O Gans; T J Vervaat; G Zevenbergen; D Maingay; R E Nikkels; A J Donker; A E von dem Borne; R Goldschmeding
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

5.  Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis.

Authors:  W J Mayet; E Csernok; C Szymkowiak; W L Gross; K H Meyer zum Büschenfelde
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

6.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

Authors:  C O Savage; B E Pottinger; G Gaskin; C D Pusey; J D Pearson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 7.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

Authors:  C G Kallenberg; A H Mulder; J W Tervaert
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

8.  Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process.

Authors:  A H Mulder; P Heeringa; E Brouwer; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

Review 9.  Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

Authors:  J G van de Winkel; P J Capel
Journal:  Immunol Today       Date:  1993-05

10.  Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.

Authors:  E Brouwer; M G Huitema; P A Klok; H de Weerd; J W Tervaert; J J Weening; C G Kallenberg
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307
View more
  14 in total

1.  Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.

Authors:  K Nishiya; H Chikazawa; S Nishimura; N Hisakawa; K Hashimoto
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

2.  Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase.

Authors:  J J Yang; R Kettritz; R J Falk; J C Jennette; M L Gaido
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 3.  ANCA testing. New developments and clinical implications.

Authors:  A E Ahmed; J B Peter; Y Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane.

Authors:  M De Bandt; O Meyer; L Dacosta; C Elbim; C Pasquier
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

6.  Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

Authors:  C Roozendaal; M H Zhao; G Horst; C M Lockwood; J H Kleibeuker; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

7.  Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman.

Authors:  M H Al-Maini; E M El-Ageb; S S Al-Wahaibi; Y Al-Farsi; E R Richens
Journal:  Rheumatol Int       Date:  2003-04-02       Impact factor: 2.631

8.  Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.

Authors:  R Mahadeva; A C Dunn; R C Westerbeek; L Sharples; D B Whitehouse; N R Carroll; R I Ross-Russell; A K Webb; D Bilton; D A Lomas; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

9.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  Central retinal artery occlusion in Wegener's granulomatosis: a diagnostic dilemma.

Authors:  Virginia Lozano-López; Beatriz Rodríguez-Lozano; María José Losada-Castillo; Esmeralda Delgado-Frías; David Dopazo-Luque; Miguel Serrano-García
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.